BiotechTube
Novex Innovations

Novex Innovations

San Diego, United States· Est.
novexinnovations.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $2M

Overview

Novex Innovations is a full-service CDMO targeting the underserved niche of startups and small-to-medium enterprises in the life sciences sector. It offers integrated services across product and process development, cGMP manufacturing, regulatory support, and commercialization from its 36,000 sq. ft. facility in San Diego. The company's mission is to accelerate the translation of healthcare innovations to market by providing reliable expertise, with a focus on biologics, drugs, and medical devices. As a private company, it operates on a service-based business model and is in a revenue-generating stage.

Drug DeliveryMedical Devices

Technology Platform

Integrated CDMO service platform across four divisions: Biologics & Tissue, Drug, Device, and Distribution. Provides end-to-end process development, cGMP manufacturing, regulatory support, and commercialization services.

Funding History

1
Total raised:$2M
Grant$2M

Opportunities

The growing trend of outsourcing by virtual and small biotech companies, coupled with the complexity of new biologic and cell therapy modalities, creates sustained demand for specialized CDMO services.
Novex's niche focus on startups and SMEs in the vibrant San Diego biotech hub positions it to capture clients who may be underserved by larger CDMOs.

Risk Factors

Novex faces significant client concentration risk, where its revenue depends on the success of a limited number of partners.
It operates in an intensely competitive CDMO landscape and is exposed to operational risks, including potential regulatory compliance failures or quality issues at its single facility, which could damage its critical reputation.

Competitive Landscape

Novex competes in a fragmented but crowded CDMO market, ranging from global giants like Lonza and Catalent to numerous regional and niche specialists. Its primary competitive differentiation is its targeted focus on startups and SMEs and its offering of integrated services across drugs, biologics, and devices from a single site, aiming for a partnership approach rather than a transactional vendor relationship.

More companies in Small Molecule Drugs →More companies in United States →